CIK 0001832038
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851403134
- Phone
- +1 781-819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-10 | MCGUIRE TERRANCE Director | Conversion · Series B Preferred Stock | −583 | 0 | ||
| 2021-08-10 | MCGUIRE TERRANCE Director | Conversion · Series B Preferred Stock | −850 | 0 | ||
| 2021-08-10 | MCGUIRE TERRANCE Director | Conversion · Series B Preferred Stock | −44,076 | 0 | ||
| 2021-08-10 | MCGUIRE TERRANCE Director | Conversion · Series C Preferred Stock | −123,574 | 0 | ||
| 2021-08-10 | MCGUIRE TERRANCE Director | Conversion · Series C Preferred Stock | −2,409 | 0 | ||
| 2021-08-10 | MCGUIRE TERRANCE Director | Conversion · Series C Preferred Stock | −846 | 0 | ||
| 2021-08-10 | MCGUIRE TERRANCE Director | Conversion · Series C Preferred Stock | −1,235 | 0 | ||
| 2021-08-10 | MCGUIRE TERRANCE Director | Conversion · Series C Preferred Stock | −32,016 | 0 | ||
| 2021-08-10 | MCGUIRE TERRANCE Director | Conversion · Series C Preferred | −64,032 | 0 | ||
| 2021-08-05 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +35,593 | 35,593 |
Page 3 of 3 · 50 trades